share_log

Oppenheimer Upgrades AngioDynamics to Outperform, Announces $12 Price Target

Oppenheimer Upgrades AngioDynamics to Outperform, Announces $12 Price Target

奧本海默將AngioDynamics上調至跑贏大盤,宣佈目標股價爲12美元
Moomoo 24/7 ·  04/05 08:40

Oppenheimer analyst Steven Lichtman upgrades AngioDynamics (NASDAQ:ANGO) from Perform to Outperform and announces $12 price target.

奧本海默分析師史蒂芬·利希特曼將AngioDynamics(納斯達克股票代碼:ANGO)從表現上調至跑贏大盤,並宣佈目標股價爲12美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論